藥用甘油基產品市場規模、佔有率及成長分析（依藥物類型、劑型、應用、最終用戶及地區分類）－2026-2033年產業預測

預計到 2024 年，全球藥用甘油產品市場規模將達到 2.871 億美元，到 2025 年將成長至 3.2327 億美元，到 2033 年將成長至 8.3537 億美元，在預測期（2026-2033 年）內複合成長率為 12.6%。

全球藥用甘油產品市場正經歷顯著成長，這主要得益於甘油作為添加劑和活性成分的多樣化作用。甘油因其保濕、潤滑和甜味功效而備受認可，在包括外用皮膚治療劑、眼用溶液、止咳藥和栓劑在內的多種藥物製劑中發揮著重要作用。慢性皮膚病和眼科疾病（包括青光眼）的日益普遍，進一步推動了甘油作為眼壓降低劑的需求。對高純度藥用級甘油的需求趨勢，凸顯了消費者和監管機構對安全、潔淨標示產品的關注。儘管競爭激烈，杜邦、黑田國際和陶氏化學等主要企業仍在擴大產能，以滿足不斷成長的市場需求。

推動全球藥用甘油產品市場發展的因素

全球藥用甘油產品市場的主要驅動力是市場對藥用級原料日益成長的需求。甘油是一種無毒的保濕添加劑，能夠增強多種藥品（包括止咳糖漿、外用乳膏和眼藥水）的療效。個人護理產業的蓬勃發展進一步推動了這一需求的成長，消費者越來越傾向於選擇含有天然植物成分的產品，例如保濕霜和消毒劑。因此，這些應用領域對高純度甘油的需求至關重要，凸顯了甘油在製藥和個人護理行業中的重要角色。

限制全球藥用甘油產品市場的因素

導引甘油類藥物市場發展的一大挑戰是關鍵原物料價格波動。這些原料主要來自棕櫚油、大豆油和芥花籽油等植物油，也用於生質柴油生產。價格波動造成了市場環境的不確定性，使生產者難以準確估算成本。這種不確定性可能導致生產商不願簽訂長期合約，並推遲投資決策，可能損害市場穩定性和行業成長潛力。

甘油類藥物的全球市場趨勢

全球甘油基醫藥產品市場正經歷一場由人工智慧 (AI) 和機器學習技術融合所驅動的變革。這些先進的解決方案正在革新生產方式，並提升整個供應鏈的品管。透過最佳化批量生產和實現即時過程控制，人工智慧和機器學習能夠幫助製造商提高效率並降低營運成本。此外，預測分析有助於預測維修需求，最終打造更具韌性和反應能力的生產環境。隨著這些技術的不斷發展，它們有望重塑行業標準，並催生出更多創新且永續的甘油基產品。

目錄

介紹

• 調查目標
• 市場定義和範圍

調查方法

• 調查過程
• 二手資料和一手資料方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭格局概述

市場動態與展望

• 總體經濟指標
• 促進因素和機遇
• 限制與挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場考察

• 關鍵成功因素
• 影響市場的因素
• 關鍵投資機會
• 生態系測繪
• 市場吸引力指數（2025）
• PESTEL 分析
• 價值鏈分析
• 定價分析
• 案例研究
• 監管環境
• 技術評估
• 技術評估
• 監管環境

全球藥用甘油類產品市場規模（按藥物類型和複合年成長率分類）（2026-2033 年）

• 皮膚科
• 眼科
• 止咳藥
• 甘油直腸劑
• 其他

全球藥用甘油基產品市場規模（按配方和複合年成長率分類）（2026-2033 年）

• 糖漿和酏劑
• 外用液
• 栓劑
• 眼藥水和口服液
• 藥物傳輸添加劑

全球藥用甘油基產品市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 配方中的添加劑
• 保濕劑和潤濕劑的應用
• 藥用溶劑/甜味劑
• 藥物穩定化和藥物遞送
• 特殊治療應用

全球藥用甘油基產品市場規模（按最終用戶分類）及複合年成長率（2026-2033 年）

• 製藥公司
• 合約配藥公司
• 醫院和臨床藥房
• 研究和學術機構
• 專業製藥製造商

全球藥用甘油基產品市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• BASF SE
• Dow Inc.
• Glycerin Products LLC
• Cargill, Incorporated
• Wilmar International Limited
• Kraton Corporation
• Emery Oleochemicals
• Vantage Specialty Chemicals
• Croda International plc
• DuPont de Nemours, Inc.
• Capsugel（Lonza）
• ABBVie Inc.
• Johnson & Johnson
• Abbott Laboratories
• Bausch Health Companies Inc.
• Takeda Pharmaceutical Company
• The Dow Chemical Company
• IOI Oleochemical（Oleon）
• KLK OLEO
• Archer Daniels Midland Company

結論與建議

Global Pharmaceutical Glycerin Based Products Market size was valued at USD 287.1 million in 2024 and is poised to grow from USD 323.27 million in 2025 to USD 835.37 million by 2033, growing at a CAGR of 12.6% during the forecast period (2026-2033).

The market for global pharmaceutical glycerin-based products is experiencing significant growth driven by glycerin's diverse roles as an excipient and active ingredient. Recognized for its effectiveness as a humectant, lubricant, and sweetening agent, glycerin plays a vital role in various pharmaceutical formulations, such as topical skin treatments, ocular solutions, cough medications, and suppositories. The rising prevalence of chronic skin conditions and eye disorders, including glaucoma, further propels demand for glycerin's use in reducing intraocular pressure. A trend towards sourcing high-purity, pharmaceutical-grade glycerin underscores a consumer and regulatory focus on safe, clean-label products. While competition is robust, major players like DuPont, Croda International, and The Dow Chemical Company are enhancing production capacity to cater to the increasing market demands.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Glycerin Based Products market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Glycerin Based Products Market Segments Analysis

Global Pharmaceutical Glycerin Based Products Market is segmented by Drug Type, Formulation, Application Area, End User and region. Based on Drug Type, the market is segmented into Dermatological, Ophthalmic, Cough Remedies, Glycerin Rectal and Others. Based on Formulation, the market is segmented into Syrups & Elixirs, Topical Solutions, Suppositories, Eye / Oral Solutions and Excipients for Drug Delivery. Based on Application Area, the market is segmented into Excipients in Formulation, Moisturizing & Humectant Uses, Solvent / Sweetener in Medicines, Drug Stabilization & Delivery and Specialty Therapeutic Uses. Based on End User, the market is segmented into Pharmaceutical Manufacturers, Contract Formulators, Hospitals & Clinical Pharmacies, Research & Academic Institutions and Specialty Drug Producers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Glycerin Based Products Market

The global pharmaceutical glycerin-based products market is primarily driven by the increasing demand for pharmaceutical-grade ingredients. Glycerin serves as a non-toxic, moisturizing excipient that enhances the efficacy of various medications, including cough syrups, topical creams, and eye solutions. This growing demand is further bolstered by the personal care sector, where consumers are increasingly inclined to choose products featuring natural, plant-derived ingredients, including moisturizers and germicidal sanitizers. Consequently, the need for high-purity glycerin becomes essential in these applications, highlighting its pivotal role in both the pharmaceutical and personal care industries.

Restraints in the Global Pharmaceutical Glycerin Based Products Market

A significant challenge hindering the advancement of the pharmaceutical glycerin-based products market is the variability in prices of their key feedstock, primarily derived from vegetable oils such as palm, soybean, and canola oils, which are also utilized in biodiesel production. These price fluctuations create an environment of unpredictability, making it difficult for manufacturers to estimate costs accurately. This uncertainty may lead to hesitation in committing to long-term contracts and can result in delayed investment decisions, ultimately diminishing market stability and growth potential within the industry.

Market Trends of the Global Pharmaceutical Glycerin Based Products Market

The Global Pharmaceutical Glycerin Based Products market is witnessing a transformative trend driven by the integration of artificial intelligence and machine learning technologies. These advanced solutions are revolutionizing production methodologies and enhancing quality management throughout the supply chain. By optimizing batch production and facilitating real-time process control, AI and machine learning enable manufacturers to improve efficiency and reduce operational costs. Furthermore, predictive analytics aid in forecasting maintenance requirements, ultimately fostering a more resilient and responsive production environment. As these technologies continue to evolve, they are expected to reshape industry standards, leading to more innovative and sustainable glycerin-based product offerings.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment
• Technology Assessment
• Regulatory Landscape

Global Pharmaceutical Glycerin Based Products Market Size by Drug Type & CAGR (2026-2033)

• Market Overview
• Dermatological
• Ophthalmic
• Cough Remedies
• Glycerin Rectal
• Others

Global Pharmaceutical Glycerin Based Products Market Size by Formulation & CAGR (2026-2033)

• Market Overview
• Syrups & Elixirs
• Topical Solutions
• Suppositories
• Eye / Oral Solutions
• Excipients for Drug Delivery

Global Pharmaceutical Glycerin Based Products Market Size by Application Area & CAGR (2026-2033)

• Market Overview
• Excipients in Formulation
• Moisturizing & Humectant Uses
• Solvent / Sweetener in Medicines
• Drug Stabilization & Delivery
• Specialty Therapeutic Uses

Global Pharmaceutical Glycerin Based Products Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical Manufacturers
• Contract Formulators
• Hospitals & Clinical Pharmacies
• Research & Academic Institutions
• Specialty Drug Producers

Global Pharmaceutical Glycerin Based Products Market Size & CAGR (2026-2033)

• North America (Drug Type, Formulation, Application Area, End User)
  • US
  • Canada
• Europe (Drug Type, Formulation, Application Area, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Drug Type, Formulation, Application Area, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Drug Type, Formulation, Application Area, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Drug Type, Formulation, Application Area, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• BASF SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dow Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glycerin Products LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cargill, Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wilmar International Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kraton Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emery Oleochemicals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vantage Specialty Chemicals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Croda International plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DuPont de Nemours, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Capsugel (Lonza)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ABBVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Dow Chemical Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IOI Oleochemical (Oleon)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KLK OLEO
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Archer Daniels Midland Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations